Heart failure & cardiomyopathies
The Role of Bioimpedance Analysis in Overweight and Obese Patients with Acute Heart Failure: A Pilot Study
Authors' conclusion
Among overweight and obese patients with HF, BIA reduces NT-proBNP levels at 90 days compared with standard care. In addition, there is a trend towards lower incidence of AKI in the BIA-guided group.
Study context
- Population
- Overweight and obese patients admitted for acute heart failure (HF)
- Participants
- 48 participants
- Comparison
- Bioelectrical impedance analysis (BIA)-guided management vs standard care
- Primary endpoint
- Severe AKI (serum creatinine increase >0.5 mg/dL)
- Follow-up
- During hospitalization
Methodological detailssingle-centre, single-blind
- Single-centre
- Single-blind
Primary result
As reported in the abstract
Severe AKI
Lower incidence of severe acute kidney injury (AKI) with BIA-guided, not significant
41.4% vs. 16.7%
Secondary outcomes
NT-proBNP < 1000 pg/mL (main secondary endpoint) · 90 days
P = 0.049
Safety
Adverse outcomes · 90 days
- No differences in incidence of adverse outcomes
Original publication
The Role of Bioimpedance Analysis in Overweight and Obese Patients with Acute Heart Failure: A Pilot Study. ESC Heart Fail. Published 24 May 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →